Abstract
Development of new drug acting on the CD16 receptor for the treatment of autoimmune diseases and septic shock Introduction: Despite half a century of research, sepsis is still a major cause of death in intensive care units, and constant source of concern throughout the world, mainly due to the high morbidity and mortality rates. Likewise, lupus provides tremendous cost to the individual a…